Q1 2023 Holdings
Filed 2023-05-10 | 24 holdings | $247.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alpine Immune Sciences, Inc. | COM | 010392595 | $51.8M | 6,708,288 | 20.9% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $31.4M | 1,824,583 | 12.7% |
| 10x Genomics, Inc.(TXG) | CL A COM | 88025U109 | $20.1M | 359,554 | 8.1% |
| Illumnia, Inc.(ILMN) | COM | 452327109 | $18.8M | 80,859 | 7.6% |
| Pacific Biosciences of California, Inc.(PACB) | COM | 69404D108 | $17.0M | 1,463,872 | 6.8% |
| Cue Health Inc.(HLTHQ) | COM | 229790100 | $16.3M | 8,980,909 | 6.6% |
| Prometheus Biosciences, Inc. | COM | 74349U108 | $16.1M | 150,000 | 6.5% |
| Arcus BioSciences, Inc.(RCUS) | COM | 03969F109 | $15.9M | 869,790 | 6.4% |
| Argenx SE(ARGX) | SHS | 04016X101 | $10.2M | 27,429 | 4.1% |
| Horizon Therapeutics PLC | COM | G46188101 | $8.6M | 78,900 | 3.5% |
| Terns Pharmaceuticals, Inc.(TERN) | COM | 880881107 | $8.5M | 714,285 | 3.4% |
| BeyondSpring Inc.(BYSI) | SHS | G10830100 | $5.6M | 4,958,143 | 2.2% |
| Seagen Inc. | COM | 812578102 | $4.7M | 23,014 | 1.9% |
| Aadi Bioscience, Inc.(WHWK) | COM | 00032Q104 | $3.8M | 526,329 | 1.5% |
| Mersana Therapeutics, Inc. | COM | 59045L106 | $3.7M | 904,268 | 1.5% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $3.3M | 580,000 | 1.3% |
| Equillium Inc.(EQ) | COM | 29446K106 | $3.2M | 4,447,308 | 1.3% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $2.7M | 293,333 | 1.1% |
| AtriCure Inc.(ATRC) | COM | 04963C209 | $1.9M | 46,259 | 0.8% |
| Scynexis Inc.(SCYX) | COM NEW | 811292200 | $1.7M | 555,555 | 0.7% |
| GeneDx Holdings Corp.(SMFRUSD) | COM CL A | 81663L101 | $1.2M | 3,418,929 | 0.5% |
| Apexigen, Inc. | COM | 03759B102 | $922.6K | 1,894,551 | 0.4% |
| Owlet, Inc. | COM CL A | 69120X107 | $291.4K | 898,400 | 0.1% |
| NeuBase Therapeutics, Inc. | COM | 64132K102 | $185.0K | 1,000,000 | 0.1% |